NCT04807374View on ClinicalTrials.gov

Hybrid Closed Loop in High Risk Youth With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

March 22, 2023

Study Completion Date

June 22, 2023

Conditions
Type 1 Diabetes
Interventions
DEVICE

Control IQ

We aim to conduct a non-randomized prospective interrupted time series pilot study to investigate the effect of HCL insulin delivery on glycemic control in underserved adolescents with poorly controlled T1D.

Trial Locations (1)

20010

Children's National, Washington D.C.

Sponsors
All Listed Sponsors
collaborator

Tandem Diabetes Care, Inc.

INDUSTRY

collaborator

DexCom, Inc.

INDUSTRY

lead

Children's National Research Institute

OTHER